West Hill Capital is a private equity and venture capital firm that originates globally scalable technology companies for private investors and family offices.
The over-subscribed funding round was organised by West Hill Capital to support the deployment of Lilli's machine learning care platform.
"The timing for this new preventative approach to care and integration of our smart technology is crucial in meeting the needs of ageing population, this has only been exacerbated by COVID 19. The role of technology has a vital role to play in the future success of care delivery across the UK and globally."
West Hill Capital backed the seed follow on round to support new product development and international expansion.
"West Hill was most impressed with TestCard’s management team and technology and believed that the company would make a significant addition to our portfolio. TestCard is now perfectly positioned to benefit from a new world where home testing for a multitude of medical conditions or illnesses has become necessary in order to alleviate the strain on our healthcare services."
West Hill Capital led the oversubscribed follow-on investment to fund team growth and product expansion.
"One of our key goals is to eliminate all forms of rental deposits including £4.5bn of cash tied up in rental deposits and deposit alternative products by December 2021."
The oversubscribed round was led by West Hill Capital to support team expansion and product development.
"We are experiencing significantly faster adoption of our technology with deal cycle time considerably reduced. This funding round will enable us to fast track our expansion plans and develop new functionality in order to meet growing demand."
The funding round was led by West Hill Capital and values the healthcare technology company at £47.6m.
"This latest round of funding shows that investors are just as excited as we are about the possibility for Visionable to make a real difference to the healthcare industry in the next decade. With just limited funding so far, we have helped the NHS save both lives and thousands of pounds, so there is no limit on what we can continue to achieve"
